- Profile
- Personal Information
- Publications
Experts in Pulmonology
Darryl C. Zeldin Charlene McEvoy Theo Pelzer Manoj J. Mammen Archana Mishra John J. Marini SAMANTHA DAVIS LUTANA HAAN Dave Allen Zsolt Papai Peter Nagy Gábor Papp Ronan O’Caoimh Levente Bartha Ildikó Breining Brian Mann M. Jeffery Mador Ernesto Petroselli Aniko Bécsy-Nemes Janos Mucsi View MoreRon Wolff, Ph.D. was appointed vice president of regulatory affairs and toxicology in 2015 following several years as Pulmokine’s consultant on regulatory affairs. He will assist Pulmokine with regulatory matters and preparation of the company’s Investigation New Drug (IND) application for an inhaled PDGFR inhibitor. Dr. Wolff is president of RK Wolff Safety Consulting Inc. He is a former executive director of preclinical safety assessment for Novartis; senior fellow in toxicology at Nektar Therapeutics in San Carlos, California; group leader of inhalation toxicology at Eli Lilly; and senior scientist at Lovelace Inhalation Toxicology Research Institute. He has experience in toxicology in a wide range of areas, including respiratory, oncology, endocrine, infectious disease, and biologics with special expertise in inhalation toxicology with applications to pharmaceuticals and environmental and occupational health.
Inhalation toxicology, pharmaceutical aerosols, leachables and extractables, and oncology